Last year the skin care company received a patent for its biotech silk protein ingredient, and now Silk Therapeutics has big plans for the millions of dollars raised during its just-closed series A2 financing round.
Specialty biotechnology company Silk Therapeutics announced late last month that the US Patent and Trademark Office granted a patent for its non-GMO, stable liquid silk protein. Cosmetics Design connected with that company’s CEO, Greg Altman, to get the...